Krilogy Financial LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Krilogy Financial LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, HoldingsChannel.com reports. The firm acquired 1,881 shares of the company’s stock, valued at approximately $890,000.

A number of other large investors have also bought and sold shares of the stock. Norges Bank purchased a new position in HCA Healthcare during the 2nd quarter valued at about $1,152,408,000. Pacer Advisors Inc. raised its holdings in shares of HCA Healthcare by 6,115.3% during the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after acquiring an additional 896,437 shares in the last quarter. Viking Global Investors LP increased its position in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of HCA Healthcare during the second quarter valued at about $109,337,000. Finally, HRT Financial LP purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $81,596,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 13,520 shares of company stock valued at $6,894,067. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

NYSE HCA opened at $539.91 on Friday. The company has a market capitalization of $120.73 billion, a price-to-earnings ratio of 19.02, a PEG ratio of 1.64 and a beta of 1.36. The stock has a 50-day moving average of $482.80 and a 200 day moving average of $448.23. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $552.90.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. During the same period in the previous year, the business posted $6.22 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.99%.

Analyst Ratings Changes

A number of brokerages recently issued reports on HCA. Bank of America lifted their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. Jefferies Financial Group upped their price target on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Cantor Fitzgerald boosted their target price on HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Robert W. Baird lifted their price target on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Finally, Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a research note on Monday, December 15th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $523.27.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s share performance is strong on a year‑over‑year basis (shares up ~75% YoY), reinforcing momentum and investor confidence in the company’s results and outlook. Read More.
• Positive Sentiment: Zacks and other analysts highlight earnings growth and price strength; Zacks added HCA to focus coverage and raised FY‑2026 EPS estimates, supporting forward earnings momentum and valuation. Read More.
• Positive Sentiment: HCA raised its quarterly dividend (new quarterly payout announced), which narrows yield risk and is a modest positive for income‑oriented investors. Read More.
• Positive Sentiment: Large institutional flows and stake increases (e.g., Norges Bank, Pacer, Viking Global) point to strong institutional demand and provide technical/supportive buying pressure for the stock. Read More.
• Neutral Sentiment: HCA completed a 43‑hospital EHR rollout and is tracking success metrics — operational execution that can improve efficiency and integration over time but has a gradual, not immediate, earnings impact. Read More.
• Neutral Sentiment: Local expansion moves — HCA Houston Healthcare Tomball acquired Supreme Care ER and StoneSprings plans a freestanding ER conversion — small, market‑level capacity adds that could modestly lift volumes in those geographies. Read More.
• Neutral Sentiment: HCA sold ASC real estate — a financing/portfolio move that could free capital or change lease terms; impact depends on transaction use of proceeds. Read More.
• Negative Sentiment: Insider selling: two senior VPs disclosed multi‑million dollar sales (Christopher Wyatt sold ~$2.0M; Jennifer Berres sold ~$4.13M). Significant insider sales can create short‑term selling pressure or raise governance/portfolio‑rebalancing questions. Read More. Read More.
• Negative Sentiment: Zacks/other outlets flagged a downward revision to HCA’s Q1 EPS forecast, which can pressure near‑term expectations even as FY estimates were raised. Read More.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.